Michael Kelly Joins Haemonetics as President, North America and Global Plasma Business

Jun 30, 2010, 16:15 ET from Haemonetics Corporation

BRAINTREE, Mass., June 30 /PRNewswire-FirstCall/ -- Haemonetics Corporation (NYSE: HAE) announced today that Michael Kelly will join its executive team effective July 12, 2010 as President, North America and Global Plasma Business.

Mike, age 46, joins Haemonetics from CareFusion, a leading medical device company focused on the reduction of medication related errors and hospital-acquired infections.  Mike most recently served as Senior VP and General Manager of CareFusion's Infection Prevention business, a $300 million global leader in its category.  Prior to his most recent position at CareFusion, Mike held a number of progressively responsible positions in sales leadership, marketing, operations and general management at Baxter Health Care and Cardinal Healthcare.  Mike earned a Bachelor's degree in Business Administration and an MBA from the Ohio State University.

Mike's responsibilities will include leadership of  the North American Patient and Donor Divisions, the Global Plasma business, Regional Marketing, Customer Solutions Implementation and Customer Support and Services.

Haemonetics' CEO Brian Concannon said, "Throughout his career, Mike has repeatedly demonstrated the ability to generate strong top line growth through exceptional customer relationships. Our vision to be the global leader in blood management solutions for our customers depends on meeting and exceeding our customers' expectations.  I'm excited about a leader of Mike's depth and breadth to bring blood management solutions to the next level of meeting and exceeding our customers' requirements."

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers.  Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world.  Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services.  To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.


Bryanne Salmon

Tel. (781) 356-9613


SOURCE Haemonetics Corporation